FOCUS Guidelines and Adherence to Physical Activity in Ageing Women.
Impact of FOCUS Guidelines on Adherence to Physical Activity in Ageing Women.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
The objectives of the study consisted of assessing i) whether the use of the Guidelines derived from the European project FOCUS had an effect on the adherence to a physical activity (PA) program (primary objective), and ii) the effect of the program, which included 2 h/week of PA, on a group of dimensions related with general health, frailty, psycho-cognitive parameters, and quality of life (QoL) (secondary objectives).
The study comprised 24 weeks in which a group of 90 postmenopausal women were randomised to three arms, two in which participants were performing PA, and one control (no intervention).
The first PA group followed the FOCUS guidelines, in which women received monthly health talks and had an internet mailbox to facilitate contact with health professionals.
The PA program consisted of a twice per week 1-hour session along 24 weeks. This period was divided into two parts, a first supervised phase in which women followed group sessions under direct supervision of a monitor, and a second period in which the groups of women followed the same exercise pattern, but autonomously. A mobile phone support system (social network whatsapp) was used for inter-connection and mutual support during the autonomous period. Assessments were performed at baseline and then at 12 weeks and 24 weeks, representing the completion of the supervised and the autonomous periods, respectively.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Valencia, Spagna, 46010
- Hosp Clinico Universitario-INCLIVA
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
Community living postmenopausal women capable of performing the physical activity program and with ability to sign the informed consent.
Exclusion Criteria:
Physical or psychological deficiencies incapacitating subjects to participate in the established physical program.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Focus guidelines
Participants enrolled in a 2-phase physical activity program divided in 2 phases as described above. Briefly, The activity consisted in a 1-h set of exercises twice per week. The first 12-week phase was performed in group under the direct supervision of a health monitor. The second 12-week phase was autonomous, and consisted of the same physical performance while maintaining virtual link through a social network based on the mobile phone. The FOCUS guidelines provided 2 features, the participation in monthly health talks provided by the principal investigator and the availability of a virtual mailbox to transmit any comment or suggestion. |
Physical activity as described previously.
|
|
Comparatore attivo: Active group
Participants enrolled in a 2-phase physical activity program divided into 2 phases as described above.
This group lacked the monthly talks and did not have access to the virtual mailbox.
|
Physical activity as described previously.
|
|
Nessun intervento: Inactive
Women of similar clinical characteristic who did not participate in the PA program.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Adherence: Level of adherence to the program as assessed by attendance to the physical activity sessions.
Lasso di tempo: 6 months
|
Attendance will be measured as a percentage of the total number of sessions.
|
6 months
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Frailty: changes in frailty as assessed by the Fried index
Lasso di tempo: 6 months
|
Changes in frailty as assessed by the Fried index, which has 5 dimensions and describes a robust state (negative for all the three criteria) in addition to the pre-frail (positive for 1 or 2 criteria) and frail (positive at least in 3 criteria) status.
|
6 months
|
|
Cognitive function
Lasso di tempo: 6 months
|
Measures as per ACE-III questionnaire
|
6 months
|
|
Mood status
Lasso di tempo: 6 months
|
Measures as per HAD questionnaire
|
6 months
|
|
Social activities
Lasso di tempo: 6 months
|
Measures as per Saint Louis questionnaire
|
6 months
|
|
Psychological well-being as measured by the 52-item Ryff scale
Lasso di tempo: 6 months
|
The Ryff scale includes 52 items designed to measure six constructs of psychological well-being: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance.
Higher total scores indicate higher psychological well-being.
Respondents rate statements on a scale of 1 to 6, where 1 indicates strong disagreement and 6 indicates strong agreement.
|
6 months
|
|
Sleep quality, measured as per Athens Insomnia scale
Lasso di tempo: 6 months
|
The Athens scale aims at assessing the insomnia symptoms in individuals with sleep disorders.
The scale measures 8 factors, which are intended to measure nocturnal sleep (5 factors) and daytime sleep-related disorders.
Factors are rated from 0 till 3 and the cumulative score gives the final outcome.
A cut-off score of 6 or higher is considered equivalent to the diagnosis of insomnia.
|
6 months
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Antonio Cano Sánchez, MD, University of Valencia
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- FOCUS_Valencia
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .